How Much Does Wegovy Cost in 2026? A Complete Pricing Breakdown

Wegovy (semaglutide 2.4mg) is one of the most prescribed weight loss medications in the United States. It's also one of the most expensive at list price. But what most people actually pay is significantly less - and varies hugely based on insurance, savings programs, and provider.

Here's what Wegovy actually costs in 2026 across every realistic scenario.

The List Price: $1,349/Month

Novo Nordisk sets Wegovy's list price at $1,349.02 for a 28-day supply (four weekly pens). This is the cash price before any discounts, insurance, or savings programs. Virtually nobody pays this price - it's effectively a ceiling, not a real-world number.

With Commercial Insurance

If your employer-sponsored or individual marketplace plan covers Wegovy, you're typically looking at:

• $25-$100/month copay on most covered plans
• Prior authorization required by nearly every insurer (your provider submits paperwork to prove medical necessity)
• BMI criteria: most insurers require BMI 30+ or BMI 27+ with a weight-related condition (diabetes, hypertension, sleep apnea, cardiovascular disease)

As of 2024, more plans added Wegovy coverage after the FDA approved it for cardiovascular risk reduction in patients with obesity and heart disease. This was a major expansion that pulled many Medicare Part D plans into coverage as well.

With the WegovyRx Savings Card

Novo Nordisk offers a manufacturer savings program that can drop your cost dramatically:

• $0/month if insured and covered (up to $225 off per 28-day supply, $2,700/year max)
• $499/month if insured but Wegovy is NOT covered (cash-paying through the program)
• Not available to Medicare, Medicaid, or VA patients

The savings card has been updated multiple times since Wegovy's launch. Always check current eligibility and benefit limits on Novo Nordisk's official savings page before assuming a specific price.

Without Insurance

Cash-pay patients have three realistic paths:

1. Branded Wegovy at cash price: $1,349/month

This is the "retail" price. Almost no one chooses this.

2. Branded Wegovy through NovoCare Pharmacy: ~$499/month

Novo Nordisk's direct-to-patient pharmacy offers Wegovy at $499/month for certain dose strengths as of 2024-2026, cutting the list price roughly in half for cash-paying patients.

3. Compounded semaglutide through telehealth: $150-$350/month

Licensed 503A and 503B compounding pharmacies produce semaglutide in a form distinct from branded Wegovy. This is legal under FDA shortage provisions while branded products are in shortage. You'll access it through telehealth platforms like Mochi Health, Henry Meds, Ivim Health, and similar. Monthly cost typically includes consultation, lab review, and medication.

Important: Compounded semaglutide is NOT the same product as Wegovy. It's a compounded version of the same active ingredient. Quality control varies by compounding pharmacy. Choose providers who disclose their pharmacy partners and who use 503A or 503B facilities.

Through Telehealth Platforms

Most major telehealth GLP-1 providers offer multiple options. Typical 2026 pricing structure:

Some providers bundle everything into a flat monthly fee (Mochi, Henry Meds, Ivim), while others charge separately for visits and medication (PlushCare, LifeMD). Always read the pricing breakdown carefully before committing.

Medicare and Medicaid

Medicare Part D: Historically did not cover Wegovy for weight loss. As of the 2024 FDA cardiovascular indication expansion, some Part D plans now cover Wegovy for patients with obesity and established cardiovascular disease. Coverage is still limited and plan-specific.

Medicaid: Coverage varies wildly by state. Some states cover Wegovy for specific indications, others don't cover GLP-1s for weight loss at all. Check your state's Medicaid formulary.

What We'd Recommend

For most people, the decision tree looks like:

1. Check if your insurance covers Wegovy. Call the member services number on your card. If yes, get prior auth and pay the copay.
2. If insured but not covered, try the manufacturer savings card at $499/month through NovoCare, or consider compounded semaglutide through a reputable telehealth provider for $150-$350/month.
3. If uninsured, compounded semaglutide through telehealth is typically the most affordable path.

Use our Savings Calculator to compare providers based on your specific situation, or browse all Wegovy providers to see current pricing.

The Bottom Line

The "$1,349/month Wegovy" headline is accurate but misleading. Real-world prices in 2026 range from $0 (insured + savings card) to $350 (compounded semaglutide cash-pay) for the vast majority of patients. The cheapest legitimate option depends on whether you prefer branded Wegovy with insurance friction, or compounded semaglutide with pharmacy-choice considerations.

Whichever path you take, pricing is volatile. Always verify current costs directly with the provider before committing.